1. Predictors for Pulmonary Tuberculosis Outcome and Adverse Events in an Italian Referral Hospital: A Nine-Year Retrospective Study (2013–2021)
- Author
-
Francesco Di Gennaro, Rossana Lattanzio, Giacomo Guido, Aurelia Ricciardi, Roberta Novara, Giulia Patti, Sergio Cotugno, Elda De Vita, Gaetano Brindicci, Michele Fabiano Mariani, Luigi Ronga, Carmen Rita Santoro, Federica Romanelli, Stefania Stolfa, Roberta Papagni, Davide Fiore Bavaro, Giusi De Iaco, and Annalisa Saracino
- Subjects
Infectious and parasitic diseases ,RC109-216 ,Public aspects of medicine ,RA1-1270 - Abstract
Background: The COVID-19 pandemic has undone years of progress in providing essential TB services and controlling the TB burden. Italy, a low TB burden country, has an incidence of 7.1 cases per 100,000 people. To control the TB spreading in Italy is critical to investigate the characteristics of patients with the worst outcomes and the highest risk of adverse events related to antituberculosis therapy. Therefore, we conducted a large retrospective study in TB patients admitted to the Clinic of Infectious Diseases University of Bari, Italy, in order to describe the clinical presentation and the factors associated with adverse events and outcomes. Methods: We retrospectively evaluated the patients admitted to the Clinic of Infectious Diseases from January 2013 to 15 December 2021. We stratified our cohort into two groups:
- Published
- 2022
- Full Text
- View/download PDF